# Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery

> **NCT07486570** · NA · RECRUITING · sponsor: **Medisch Spectrum Twente** · enrollment: 360 (estimated)

## Conditions studied

- Mesenteric Vascular Disease
- Colorectal Surgery
- Preventive Intervention

## Interventions

- **PROCEDURE:** Percutaneous transluminal angiopasty and endovascular stenting of the superior mesenteric artery
- **PROCEDURE:** Colon surgery
- **DRUG:** Mono antiplatelet therapy with Ascal 80mg daily

## Key facts

- **NCT ID:** NCT07486570
- **Lead sponsor:** Medisch Spectrum Twente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07486570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07486570, "Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07486570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*